Aenova sees CMO demand coming back to Europe

By Gareth Macdonald

- Last updated on GMT

CMO Aenova says demand for contract manufacturing capacity in Europe is increasing.

CEO Heiner Hoppmann told Outsourcing-pharma.com that: “We see a very clear trend that customers want to come back to Europe from Asia​.”

He also spoke about developments at the manufacturing facility in Lyon, France that Aenova leased from Skypharma in August this year​.

We decided to set up a new pilot plant for pellet manufacturing that will start operations early next year,”​ Hoppman said, explaining that this was the missing part of Aenova’s extended-release technology offering.

He went on to say that the firm has transferred two co-development projects to Lyon and is in talks about the first new customer project that will be conducted at the site, predicting that they could quintuple the amount of work carried out there.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us

Products

View more

Webinars